Delivery Order SPE2DB22D2206-SPE2DB24FJM41

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,053.71 fixed-price contract is for the supply of Hydromorphone 1 mg/ml carpujctml, a prescription medication. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,099.55 contract is for the delivery of 4568142102 - HYDROMORPHONE 1ML 10S, a pain management pharmaceutical product. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,678.80 firm-fixed-price delivery order is for the supply of hydromorphone 1 mg/ml carpujctml, a prescription opioid medication. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Hydromorphone 1 mg/ml Carpujct, a pain management medication, with a ceiling value of $1,872.86 and a period of performance through November 6, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.69 firm fixed-price delivery order is for the supply of hydromorphone 1 mg/ml carpujctml, a controlled substance medication. The contract has an ultimate completion date of November 22, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of hydromorphone 1 mg/ml carpujctml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,467.05 and a completion date of September 17, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,802.44 fixed-price delivery order is for the supply of 4563150342 - Hydromorphone 1 mg/ml carpujctml, with a performance period through December 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Hydromorphone 1 mg/ml, a pain management medication, with a ceiling value of $2,705.56 and a period of performance through May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone 0.5 mg/0.5 ml 0.5 ml medication. The contract, valued at $1,001.01, has a period of performance through May 8, 2025. Amerisourcebergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is the prime contractor. This award is not set-aside and is part of a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Hydromorphone 1ML 10S, a pharmaceutical product. The $1,271.61 delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJM41
    Delivery Order

This is a $3,889.22 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/28/24, 9:55 AM